In order to evaluate the predictive power of the CD40LG/GBP2 two-gene signature in the accurate classification of HAM/TSP and ATLL samples, we conducted a validation step using independent datasets, which revealed excellent predictive values. The gene discussed is GBP2; the disease is adult T-cell leukemia/lymphoma.